Engineering Challenges in Designing Pharmaceutical Isolators
In this latest blog, James Lau, one of 3P’s Project Engineers, tells us all about barrier systems across a range of areas. Specifically taking a...
Tom French : 28 July 2025
This article traces the evolution of API-in-capsule (AIC) technology, from its early disruption of traditional formulation through the Xcelodose® system, to its reinvention in 3P innovation’s Fill2Weight platform. The authors explore how AIC has shifted from a risky bet to a scalable solution for modern drug development. Looking ahead, they highlight the transformative role AIC can play in personalised medicine, oncology, and DPI, where flexibility and precision are key to success.
Authors:
In this latest blog, James Lau, one of 3P’s Project Engineers, tells us all about barrier systems across a range of areas. Specifically taking a...
In early-stage pharmaceutical development, poor powder flow is rarely the root issue, it’s simply a symptom. The real challenge for formulation...
Pouches are widely used in medical device packaging to provide a sterile barrier when the device itself, or its primary container, cannot inherently...